Using our expertise in RNA, Mercurna and RiboPro are joining the fight against SARS-COV-2 (which is an RNA virus) by supporting the development of a next-generation face mask.
The new mask is under development by start-up Lumaero and uses innovative technology and design for improved comfort, ease of use and protection (both of wearer and surroundings). The mask does not use any consumable parts and may be useful for healthcare professionals and private individuals.
Mercurna and RiboPro contribute to the development by testing the destruction of RNA, as a measure of viral inactivation, by the mask. We are thankful for the support by the Pivot Park for these activities.
Stay tuned for updates.